December 10, 2024 - 00:34

A man has been taken into custody in Pennsylvania following the tragic killing of Brian Thompson, the CEO of UnitedHealthcare. Authorities have confirmed that the suspect was found in possession of a weapon that is consistent with the firearm used in the murder. This development has sparked a significant investigation into the circumstances surrounding Thompson's death.
Thompson, who was a prominent figure in the health insurance industry, was known for his leadership and contributions to the field. His untimely death has sent shockwaves through the community and raised concerns about safety and security in the area. Law enforcement officials are working diligently to piece together the events leading up to the incident, and they are urging anyone with information to come forward.
As the investigation unfolds, the focus remains on understanding the motive behind this violent act and ensuring that justice is served for Thompson and his family. The case has drawn widespread attention, highlighting the ongoing issues of gun violence and public safety in the United States.
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...
May 12, 2026 - 10:26
Shortage of beds, staff force Michigan kids out of state for mental health treatmentMichigan children facing severe mental health crises are increasingly being transported out of state for treatment, sometimes traveling thousands of miles away from their families. The root cause...
May 11, 2026 - 17:47
Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer`s drugs, leaving Medicare spending well below earlier government forecasts. The new class of amyloid-targeting treatments, including...